|
Market Closed -
Nasdaq
21:00:00 06/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 1.040 USD | -4.59% |
|
-11.86% | -24.09% |
| 11-06 | Allogene Therapeutics, Inc., Q3 2026 Earnings Call, Nov 05, 2026 | |
| 11-05 | Allogene Therapeutics, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2026 | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ALLO | Delayed | |
CBOE
| ALLO | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 1.29 | 1.46 | 1.74 |
| Spread/Res. | -19.38% | -28.77% | -40.23% |
| Spread/Supp. | +9.15% | +9.15% | +27.76% |
| Support | 0.9528 | 0.9528 | 0.814 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ALLO Stock
- Charts Allogene Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
